CD4 and acquired idiopathic inflammatory myopathy: At the periphery, our findings in IIM revealed that CD4+ T cells from peripheral blood of patients with IIM display the same truncation of the N-glycosylation pathway as observed in the tissue, suggesting that CD4+ T glycoprofile can be a proxy for what is happening at the muscle tissue, potentially constituting a promising non-invasive biomarker in IIM.